
I Went to Cornell. What Happened at Chi Phi Didn't Shock Me | Opinion
"I love Cornell. I got an education there that I still use every day. I also got a disease that took me years to arrest."
Browse recent medication, recall, and health-related stories.
Page 14 of 51

"I love Cornell. I got an education there that I still use every day. I also got a disease that took me years to arrest."

About 4,596 pounds of Sempio ginseng chicken stew skipped U.S. import reinspection. Product codes, the eight states, and why the check matters.

Nine eye drop listings, including Walgreens lubricant drops, are recalled over sterility concerns. Check brands, lots, and eye infection warning signs.

Blood pressure medication is one of the most common types of medicines in use in the United States. But this month, a nationwide recall has impacted more than 13,000 bottles of blood pressure medication due to a possibility that the drug may not work as expected. Here’s what you need to know. What’s happened? Earlier this month, Inventia Healthcare Limited, a pharmaceutical company based in India, initiated a voluntary recall of one of its Chlorthalidone-based blood pressure medications. However, this recall wasn’t widely publicized until later this month, when the U.S. Food and Drug Administration (FDA) posted an enforcement report in which the agency categorized the recall with a Class II designation. A Class II Recall is one in which the “ use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,” according to the FDA. A Class II categorization is the second-highest designation a recall can receive. According ot the FDA’s enforcement report, the reason for the recall is “Failed Dissolution Specifications.” As noted by Good Housekeeping , the Chlorthalidone tablets need to dissolve in the body to be most effective, and if they do not, the blood pressure medication may not work as optimally as intended. Which blood pressure medication is being recalled? According to the FDA’s enforcement report, only one blood pressure medication is included in this recall. However, the recall covers a significant amount of pills—13,567 bottles, to be exact. Those bottles were distributed nationwide; however, the enforcement report does not specify which pharmacies or other businesses distributed or received the medication. As for the blood pressure medication being recalled, the report says it includes the following chlorthalidone tablets: Product Description: Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only. Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01 Batch #: RISA24002 Exp Date: 04/2027 What should I do if I have the recalled blood pressure medication? The FDA’s enforcement notice does not tell consumers who have the medication what action to take. However, Health.com says the best course of action is to contact your doctor or pharmacist before making any changes to your medication intake.

What isn’t clear to me is whether your symptoms of fatigue and weakness are due to low testosterone after prostate cancer treatment or if it’s OPMD.

A pharmacist has shared a viral video advising people about the dangers of self-medicating with Omeprazole, a drug commonly used to treat heartburn

The Drug Discovery Outsourcing Market is valued at USD 8.1 Billion in 2025 and is expected to reach USD 20.65 Billion by 2035, growing at a CAGR of 9.9% during the forecast period (2026-2035). The market is evolving from a cost-driven
Breast cancer survivor Agnes Munien reflects on fighting the disease twice and the lifesaving power of early detection after being honoured on Temba Bavuma’s jersey at the Wanderers Pink ODI.

Inventia Healthcare recalls 13,567 bottles of chlorthalidone blood pressure tablets under FDA's Class II risk level.
Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Incident Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Cohort Studies Cureus

Blood pressure medication is one of the most common types of medicines in use in the United States. But this month, a nationwide recall has impacted more than 13,000 bottles of blood pressure medication due to a possibility that the drug may not work as expected. Here’s what you need to know. What’s happened? Earlier this month, Inventia Healthcare Limited, a pharmaceutical company based in India, initiated a voluntary recall of one of its Chlorthalidone-based blood pressure medications. However, this recall wasn’t widely publicized until later this month, when the U.S. Food and Drug Administration (FDA) posted an enforcement report in which the agency categorized the recall with a Class II designation. A Class II Recall is one in which the “ use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,” according to the FDA. A Class II categorization is the second-highest designation a recall can receive. According ot the FDA’s enforcement report, the reason for the recall is “Failed Dissolution Specifications.” As noted by Good Housekeeping , the Chlorthalidone tablets need to dissolve in the body to be most effective, and if they do not, the blood pressure medication may not work as optimally as intended. Which blood pressure medication is being recalled? According to the FDA’s enforcement report, only one blood pressure medication is included in this recall. However, the recall covers a significant amount of pills—13,567 bottles, to be exact. Those bottles were distributed nationwide; however, the enforcement report does not specify which pharmacies or other businesses distributed or received the medication. As for the blood pressure medication being recalled, the report says it includes the following chlorthalidone tablets: Product Description: Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only. Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01 Batch #: RISA24002 Exp Date: 04/2027 What should I do if I have the recalled blood pressure medication? The FDA’s enforcement notice does not tell consumers who have the medication what action to take. However, Health.com says the best course of action is to contact your doctor or pharmacist before making any changes to your medication intake.

The Drug Discovery Outsourcing Market is valued at USD 8.1 Billion in 2025 and is expected to reach USD 20.65 Billion by 2035, growing at a CAGR of 9.9% during the forecast period (2026-2035). The market is evolving from a cost-driven
Breast cancer survivor Agnes Munien reflects on fighting the disease twice and the lifesaving power of early detection after being honoured on Temba Bavuma’s jersey at the Wanderers Pink ODI.
Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Incident Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Cohort Studies Cureus